7T MRI Scan for Detecting Melanoma Brain Tumors
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the use of a powerful MRI machine, known as a 7-Tesla MRI, to detect melanoma that has spread to the brain. Standard MRIs use a less powerful magnet, but the 7-Tesla MRI may provide clearer images, potentially aiding in the earlier detection and diagnosis of brain tumors. The trial targets individuals with melanoma who have new, untreated brain tumors identified by a standard MRI. Participants must be comfortable undergoing an MRI and able to lie flat without anxiety. As an unphased trial, it offers a unique opportunity to contribute to advancements in imaging technology that could improve early detection of brain tumors.
Do I need to stop my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. It seems you may continue with previous systemic therapy, immunotherapy, or checkpoint inhibitors, but it's best to confirm with the study team.
What prior data suggests that the 7T MRI is safe for detecting melanoma brain tumors?
Research has shown that 7T MRI scans are generally safe. The stronger magnetic field of the 7T MRI produces clearer images than regular MRIs. However, some individuals might experience side effects such as dizziness, nausea, or a sense of movement during the scan. These effects are usually mild and resolve quickly. The 7T MRI offers detailed brain images, which can more effectively detect melanoma that has spread to the brain compared to the standard 3T MRI.12345
Why are researchers excited about this trial?
Researchers are excited about using 7 Tesla (7T) MRI scans to detect melanoma brain tumors because this technique offers much higher resolution images compared to the standard 3 Tesla (3T) MRI scans. This means doctors could potentially see smaller tumors and more detailed structures in the brain, leading to earlier and more accurate diagnoses. Additionally, the enhanced detail might help avoid unnecessary treatments by better distinguishing between cancerous and non-cancerous tissue. This could significantly improve patient outcomes by tailoring treatments more precisely.
What evidence suggests that 7T MRI is effective for detecting melanoma brain metastases?
Research has shown that the 7T MRI, which uses a stronger magnet, captures clearer brain images than the standard 3T MRI. This trial will involve participants undergoing a 7T MRI scan, which is particularly useful for detecting melanoma brain metastases (when melanoma spreads to the brain) at an earlier stage. Early detection is crucial as it can lead to improved treatment outcomes. Studies have found that the 7T MRI provides better image quality, making it easier to identify non-cancerous brain spots as well. This could result in a more accurate and timely diagnosis for patients whose melanoma has spread to the brain.13467
Who Is on the Research Team?
Lindsay Hwang
Principal Investigator
University of Southern California
Are You a Good Fit for This Trial?
This trial is for adults with melanoma that may have spread to the brain. Participants must be able to undergo MRI scans without distress, have a performance status indicating they can carry out daily activities, and agree to use contraception. It's not suitable for those with poor kidney function, recent neurosurgery or radiotherapy, uncontrolled illnesses, claustrophobia severe enough to prevent MRI scans, incompatible implants, or allergies to contrast agents used in MRIs.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Diagnostic
Patients undergo 7T MRI scan with and without contrast over 1-2 hours
Follow-up
Participants are monitored for safety and effectiveness after the diagnostic procedure
What Are the Treatments Tested in This Trial?
Interventions
- Magnetic Resonance Imaging using 7 Tesla MRI
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Southern California
Lead Sponsor
National Cancer Institute (NCI)
Collaborator